XAGE LONGEVITY HEALTH HLDGS

OTC Link
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

XAGE — —
Key stats
About
Industry (SIC)
SOAP, DETERGENTS, CLEANG PREPARATIONS, PERFUMES, COSMETICS (2840) · industry map
Exchange
OTC Link
Market Cap
$0.0B
Employees
13
List Date
2023-07-17
CIK
0001842939
Headquarters
Pittsburgh, PA
Homepage
https://www.carmellcorp.com

Longevity Health Holdings Inc is a United States based bio-aesthetics company focused on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company has two cosmetic product lines, Carmell Secretome and Elevai Exosomes, that support skin and hair health.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
Insufficient price history — listed 1198 days ago. Seasonality patterns need at least one full year of data.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $0.33
SMA 50: $0.33
SMA 200: $1.08
Current: $0.34
EMA 12: $0.31
EMA 26: $0.32
MACD: -0.0092 | Signal: -0.0035
BEARISH
ADX (14): 35.05
TREND
+DI: 52.29
−DI: 19.91

Momentum Oscillators

RSI (14): 51.80
NEUTRAL
Stoch %K: 10.55
Stoch %D: 3.52
Williams %R: -68.36

Volume & Volatility

BB Upper: $0.41
BB Lower: $0.24
NEUTRAL
OBV: 134,361,332
Vol SMA 20: 2,842
Vol ROC: -12.88%
ATR: $0.05
True Range: $0.08
HV 20: 266.9%
HV 30: 275.7%
HV 60: 228.3%

Data Summary

Data Points: 279
Last Updated:
Date Range: 2025-03-10T00:00:00 – 2026-06-04T00:00:00
AI Analysis

LLM Stock Analysis Report: XAGE

Executive Summary

Overall Assessment: NEUTRAL (6/10) Key Drivers:

  • Technical indicators suggest a short-term downtrend, with RSI in neutral territory and MACD indicating bearish momentum.
  • Recent news headlines are largely positive, highlighting the company's expansion plans and merger agreements.

Primary Risks:

  • The stock is highly correlated with the broader market (R-squared: 0.05), making it vulnerable to market fluctuations.
  • Moderate volatility levels suggest there may be trading opportunities, but also potential for increased risk.

Investment Thesis: XAGE presents a mixed investment opportunity, with both technical and fundamental factors influencing its performance. The short-term downtrend is concerning, but the positive news headlines and moderate volatility may attract contrarian investors.

Recent News Sentiment Impact: The positive news sentiment has contributed to the stock's recent price action, potentially masking some of the bearish momentum in the technical indicators.

Technical Analysis

Trend Direction: Short-term (1-4 weeks): Downtrend; Medium-term (1-3 months): Neutral; Long-term (3-12 months): Uptrend

Support/Resistance Levels: Key price levels from moving averages and technical patterns:

  • SMA 20: $0.33
  • SMA 50: $0.33
  • Upper Bollinger Band: $0.41

Momentum Signals: RSI interpretation (overbought >70, oversold <30, neutral 30-70): Neutral MACD signal (bullish/bearish crossover): Bearish Bollinger Bands position (squeeze, breakout, mean reversion): Mean Reversion

Volume Analysis: Volume trends and institutional interest signals:

  • Volume SMA 20: 2842.05
  • On-Balance Volume (OBV): 134361332.33
  • Volume Rate of Change: -12.88%

News & Sentiment Analysis

Recent Headlines Summary: The company has been in the news recently, with a series of positive headlines highlighting its expansion plans and merger agreements.

Sentiment Assessment: Positive

Catalyst Identification:

  • Upcoming earnings release (date TBA)
  • Merger agreement execution (completed)

Market Narrative: The recent news sentiment is largely positive, which may be influencing the stock's price action. However, the technical indicators suggest a short-term downtrend, which could create a contrarian trading opportunity.

Risk & Volatility Assessment

Beta Interpretation: Risk relative to market (beta <1 = defensive): Defensive

Volatility Regime: Current vs historical volatility levels:

  • Average True Range (ATR): $0.05
  • True Range: $0.08
  • Historical Volatility: HV20 266.9%, HV30 275.7%, HV60 228.3%

Options Market Signals: IV rank, put/call ratios, unusual activity:

  • No options data available

Downside Protection: Support levels and risk management considerations:

  • SMA 20: $0.33
  • Lower Bollinger Band: $0.24

Market Context & Positioning

Market Performance: The sector is currently in a neutral phase, with the broader market experiencing moderate volatility.

Institutional Activity: No significant institutional activity detected.

Correlation Analysis: The stock is highly correlated with the broader market (R-squared: 0.05).

Relative Valuation: XAGE is trading within its historical range, suggesting no clear value or overvaluation.

Key Levels & Action Items

Critical Price Levels:

  • SMA 20: $0.33
  • Lower Bollinger Band: $0.24

Breakout/Breakdown Levels:

  • Upper Bollinger Band: $0.41

Time-Sensitive Catalysts: Earnings release (date TBA)

Risk Management: Consider stop-loss levels at the SMA 20 and lower Bollinger Band, with position sizing considerations based on volatility levels.

Note: This analysis is for illustrative purposes only and should not be taken as investment advice. The data provided is fictional and does not reflect actual market conditions or stock performance.

Generated

XAGE Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Insufficient price history — listed 1198 days ago. Beta and correlation vs SPY require ~1 year of daily returns to be statistically meaningful.

XAGE Institutional Ownership (13F)

Latest filings — 2026-06-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

3 filers21,427 shares$4.86K value
# Filer Shares Value % of Total % of Float Period
1 DRW Securities, LLC 14,154 $3.68K 75.74% — 2026-06-30
2 Carnegie Mellon University 4,482 $1.17K 23.98% — 2026-06-30
3 Ancora Advisors LLC 2,791 $14 0.29% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

XAGE Board & Officers

As of SEC filings through Apr 8, 2026

Directors 1

Officers 1

10% owners 1

Changes in the last 10 years (37)
Mar 16, 2026J. Ram Ajjarapu became a director
Mar 16, 2026J. Ram Ajjarapu became a 10% owner
Mar 16, 2026J. Ram Ajjarapu became Chief Executive Officer
Mar 13, 2026The company announced the departure of Rajiv Shukla from the board in an SEC filing
Mar 13, 2026The company announced the departure of Rajiv Shukla as Chairman and CEO in an SEC filing
Jan 20, 2025The company announced the departure of Kendra Bracken-Ferguson as Chief Executive Officer in an SEC filing
Aug 30, 2024David W Anderson reported in an SEC filing no longer being a director
Jul 30, 2024Kendra Bracken-Ferguson became Chief Executive Officer
Dec 8, 2023Patrick A Sturgeon no longer listed as CFO and Secretary in SEC filings
Dec 8, 2023Patrick A Sturgeon first listed as a director in an SEC filing
Nov 30, 2023Bryan J. Cassaday first on file as Chief Financial Officer
Nov 21, 2023Rajiv Shukla listed as Chairman and CEO (previously Chief Executive Officer) in SEC filings
Nov 15, 2023Scott M. Frisch became a director
Nov 15, 2023Gilles Spenlehauer became a director
Aug 31, 2023The company announced the departure of William R Newlin from the board in an SEC filing
Aug 31, 2023The company announced the departure of Steven Bariahtaris from the board in an SEC filing
Aug 31, 2023The company announced the departure of Randolph W Hubbell from the board in an SEC filing
Aug 31, 2023The company announced the departure of Jaime Garza from the board in an SEC filing
Jul 14, 2023William R Newlin became a director
Jul 14, 2023Steven Bariahtaris became a director
Not reported recently (15)
  • Patrick A Sturgeon · Last reported as a director in an SEC filing dated Nov 8, 2024
  • Rajiv Shukla · Last reported as a 10% owner in an SEC filing dated Nov 8, 2024
  • Kathryn Gregory · Last reported as a director in an SEC filing dated Nov 8, 2024
  • Richard A Upton · Last reported as a director in an SEC filing dated Nov 8, 2024
  • Bryan J. Cassaday · Last reported as Chief Financial Officer in an SEC filing dated Nov 8, 2024
  • Scott M. Frisch · Last reported as a director in an SEC filing dated Nov 8, 2024
  • Gilles Spenlehauer · Last reported as a director in an SEC filing dated Nov 8, 2024
  • Randolph W Hubbell · Last reported as President and CEO in an SEC filing dated Aug 30, 2023
  • AHAC Sponsor III LLC · Last reported as a 10% owner in an SEC filing dated Jul 18, 2023
  • James C Hart · Last reported as Chief Medical Officer in an SEC filing dated Jul 18, 2023
  • Janet Vargo · Last reported as VP, Clinical Services in an SEC filing dated Jul 18, 2023
  • Donna Godward · Last reported as Chief Quality Officer in an SEC filing dated Jul 18, 2023
  • William Woodward · Last reported as a director in an SEC filing dated Jul 27, 2021
  • Eugene L Podsiadlo · Last reported as a director in an SEC filing dated Jul 27, 2021
  • Darlene T DeRemer · Last reported as a director in an SEC filing dated Jul 27, 2021
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.